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Abstract 
Articles requiring a descriptive 15-word introductory line are: Editorials, and Perspectives. 
Articles requiring short (50-word) unstructured abstracts are: Notable cases (abstract should state the 
general area of relevance, describe the specific nature of the case, and point out the 
relevance/implications for clinical practice or health policy). 
Articles requiring 4–6 bullet-point) summaries are: Clinical focus article including narrative review. 
Articles requiring structured abstracts are:  
Research reports (use the headings: Objectives, Design, Setting, Participants, Main outcome 
measures, Results, Conclusions and Trial registration [if applicable]) and  
Systematic reviews (use the headings: Objective, Study design, Data sources, Study selection, Data 
extraction, Data synthesis, Conclusions).  
Abstract word count 231 
 
Objective(s): To describe how doctors define and use the terms “futility” and “futile 
treatment” in end-of-life care. 
Design, Setting, Participants: A qualitative study using semi-structured interviews with 96 
doctors across a range of specialties who treat adults at the end of life. Doctors were recruited 
from three large Australian teaching hospitals and were interviewed from May to July 2013. 
Results: Doctors’ conceptions of futility focused on the quality and chance of patient benefit. 
Aspects of benefit included physiological effect, weighing benefits and burdens, and quantity 
and quality of life. Quality and length of life were linked, but many doctors discussed 
instances when benefit was determined by quality of life alone. Most doctors described the 
assessment of chance of success in achieving patient benefit as a subjective exercise. Despite 
a broad conceptual consensus about what futility means, doctors noted variability in how the 
concept was applied in clinical decision-making. Over half the doctors also identified 
treatment that is futile but nevertheless justified, such as short-term treatment as part of 
supporting the family of a dying person. 
Conclusions: There is an overwhelming preference for a qualitative approach to assessing 
futility, which brings with it variation in clinical decision-making. “Patient benefit” is at the 
heart of doctors’ definitions of futility. Determining patient benefit requires discussions with 
patients and families about their values and goals as well as the burdens and benefits of 
further treatment. 
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Text 
Research reports should be written in IMRAD format (Introduction, Methods, Results and 
Discussion). 
Case reports should comprise a Clinical record followed by a Discussion. 
Text word count 2,529 
 
Introduction 
Futile medical treatment is a pressing challenge for Australian clinicians and the Australian 
health system. Futile treatment can prevent a good death,1 and may cause distress to patients 
and families, as well as moral distress to health professionals.2 Additionally, futile treatment 
uses scarce health resources, denying health services to others who could benefit.3  
Despite many years of debate, the question of how to define futile treatment remains 
unresolved.4,5 The debate has been linked to the perceived conflict between patient and 
physician autonomy, with early efforts to reach consensus on a definition of futility seen as an 
attempt to address this conflict.6 However, futile treatment occurs not only because of patient 
or family request, with studies pointing to a range of contributing factors.7,8 
Although conceptualised in different ways, futile treatment has been commonly understood in 
two senses: firstly, where the likelihood that treatment will confer patient benefit is 
unacceptably low (“quantitative” futility), and secondly, where the quality of resulting patient 
benefit is unacceptably low (“qualitative” futility).9,10 Some have proposed that doctors have 
authority over the former (as medical decision-makers), and patients and families the latter 
(based on their values).11 While this dichotomy has been questioned, given that medical 
decisions necessarily include value judgements,12,13 it is generally accepted that a medical 
judgment that treatment is likely to be futile is a necessary starting point for discussing the 
value of continuing treatment. A further challenge is that advances in medicine make futility a 
moving target – new devices, procedures and medications may extend life before evidence of 
their effectiveness has been established.5,14  
These conceptual difficulties have prompted some to call for the abandonment of the term 
“futile”.15,16 Others argue it has utility in clinical decision-making, pointing to its everyday 
use in hospital settings.17 In this paper we report on the way doctors from various 
subspecialties involved in end-of-life care at three large Australian teaching hospitals 
understand the term “futility”. This research helps to fill a gap in a literature that is largely 
based on theoretical argument, rather than empirical evidence.  
Method 
We conducted 96 semi-structured interviews with doctors from three quaternary and tertiary 
public hospitals in metropolitan Brisbane. Purposive maximum variation sampling was used 
to recruit doctors from specialties that routinely deliver end-of-life care: emergency (n=15), 
intensive care (12), palliative care (10), oncology (10), renal medicine (10), internal medicine 
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(9), respiratory medicine (9), surgery (8), cardiology (5) and geriatrics (4). Four medical 
administrators were included to understand their role in disputes. Invitations were circulated 
by heads of clinical departments, and those interested contacted the research team to arrange 
an interview. Multi-centre ethics approval was obtained from the Royal Brisbane and 
Women’s Hospital. 
The sample included 87 consultants and 9 registrars, with an age range of 30 to 72 years 
(mean = 49 years). There were 68 men and 28 women, broadly reflecting the medical 
workforce.18 Doctors had worked in Australia an average of 19 years (range = 1-49 years).  
A semi-structured interview guide (Appendix 2 online at mja.com.au) was developed and 
piloted with two doctors with experience in end-of-life care. The convergent interviewing 
technique was used, which is designed to explore issues that are difficult to define.19 The 
interviews began with a general question – asking doctors to describe a situation where “a 
person got treatment at the end of life you didn’t think they should have had” – to allow 
participants to raise issues without prompting. Doctors’ definitions of futility were explored 
through case examples and by asking why they thought treatment should not have been 
provided or was “futile”. Doctors were also asked how they defined futile treatment. The 
interviews were conducted between May and July 2013 by one of the authors (EC). 
Early interviews were open-ended, and subsequent interviews looked for convergence or 
divergence on topics raised. Interviews continued until a stable pattern of agreements and 
disagreements was established and no new issues emerged.19 Interviews lasted 0.5 to 2 hours, 
with most taking 1 hour. 
Interviews were transcribed verbatim, checked for accuracy by the participant and then de-
identified. Transcripts were imported into QSR International’s NVivo qualitative analysis 
software (Version 10). The data were initially coded to extract broad themes (by NS). Three 
authors (EC, BW, LW) then did a detailed analysis of key themes and extracts. Individual 
cases were iteratively discussed to refine the coding. The framework approach was also used, 
combining thematic and case-based analysis.20 Preliminary results were presented to small 
groups of senior clinicians working in end-of-life care at each participating hospital, and to 
the project’s clinical reference group, to validate the findings. 
Results 
Defining futility as a concept 
Doctors identified various elements in their understanding of “futility” (Table 1), including 
the quality of patient benefit and the chance of achieving it. Some doctors gave more than one 
definition of futility depending on the context, but there was broad consensus about the major 
elements. Cross-tabulation between each definitional element of futility and age, gender, 
religion and specialty did not reveal differences in the pattern of responses. 
All 96 doctors conceptualised futility as about patient benefit, referring to burdens 
outweighing benefits, symptom reduction, and length and quality of life (Appendix 1, quotes 
A-F online at mja.com.au). Many doctors commented that quality of life needs to be judged 
solely from the patient’s perspective: “So it's never my decision, it's the patient's decision” 
(Oncology consultant, female). Doctors also often took a holistic approach and defined 
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futility as failing to meet patient, family or clinician “goals” (45/96) or resulting in a poor 
“overall outcome” (81/96): “It's not going to change the big picture” (Respiratory Medicine 
consultant, female). Some doctors (28/96), particularly those from ICU, used the language of 
“reversibility”. Seventeen doctors mentioned sometimes considering resource use as part of 
assessing futility (Appendix 1, quotes G-I online at mja.com.au).  
Most (70/96) doctors referred to the chance of achieving a benefit as part of defining futility. 
Some commented that assessing the chance of benefit is subjective, and points to considering 
colleagues’ opinions, patients’ wishes and other contextual factors.  
Only 4 doctors defined a numeric threshold below which treatment would be futile in all 
cases, ranging from less than 10% to “vanishingly close to zero” (Surgery consultant, male). 
Most doctors who discussed the chance of patient benefit (59/70) used words like 
“insignificant”, “negligible”, “low” or “very low” chance, suggesting that a measure could be 
futile even with some possibility of success (Appendix 1, quotes J, K online at mja.com.au). 
Thirty-one doctors gave examples of cases that were futile because there was no chance of 
success; some (7/70) would not label a treatment “futile” unless they were sure there was 
absolutely no chance of benefit (Appendix 1, quotes L-N online at mja.com.au).  
Despite wording variations, there was conceptual consistency in how doctors defined futility, 
even across specialty. We distilled the following definition from the majority, drawing largely 
on their words: 
Futile treatment is treatment that has only a very low chance of achieving meaningful benefit 
for the patient in terms of: 
 improving quality of life; 
 sufficiently prolonging life of acceptable quality; or 
 bringing benefits that outweigh the burdens of treatment. 
 
This definition represents a broad consensus of participants, and contains words that allow for 
some discretion in interpretation. For example, a “very low chance” varies between 
individuals. Further, while our definition emerges from the interview data, our focus was to 
ensure broad representation of concepts rather than reflecting all wordings. 
Futility in clinical decision-making 
Despite the high level of conceptual consensus in definitions, doctors varied in applying 
futility clinically. One renal physician noted: 
Even within our department we have different views on what is futility. You may think 
it is futile, but the family may not … So where we draw the line - that is the basic 
problem. There is a conflict everywhere. (Renal Medicine consultant, male) 
Over half of doctors (51/96) noted difficulties defining and applying the concept of futility: it 
“gets a bit grey” (Renal Medicine consultant, female) (Appendix 1, quotes O-P online at 
mja.com.au). A quarter said it is difficult to be certain about outcomes (26/96), an assessment 
complicated by the different perspectives from which benefit can be assessed (22/96). Some 
noted that using clinical guidelines (24/96) and discussion with colleagues (44/96) could 
increase the objectivity of clinical assessments (Appendix 1, quote Q online at mja.com.au). 
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Across specialties, there was broad consensus about the clinical factors relevant to futility 
determinations (Table 2). Doctors strongly favoured a multi-factorial approach where strict 
medical criteria were not determinative. This may be because these criteria vary across 
clinical contexts, but also reflects doctors’ appreciation of quality of life and avoiding harm.  
“Medical futility” and justifiable futile treatment 
Over half the doctors (52/96) discussed situations where treatment was futile but nevertheless 
justified (Appendix 1, quotes R-S online at mja.com.au). Most (42/52) spoke about family 
needs, mentioning the short-term provision of treatment for relatives to gather (14/52) and 
come to terms with the situation (33/52). Doctors also mentioned justifiable futile treatment 
that benefits the patient in non-clinical ways (24/52). Examples included fulfilling social roles 
like attending a wedding or seeing a new grandchild.  
Where patient/family benefit justified otherwise “medically futile” treatment, a few doctors 
queried whether such treatment was in fact “futile”: 
So, do I think the care was futile?… if I judge it from a cure point of view, then … yes. 
If I look at a point of view of those four days in ICU in terms of allowing family to 
come to an understanding of the futility of the care … and to… ensure that the patient 
was eventually given dignity, privacy, etcetera - actually, then the answer is no. (ICU 
consultant, male) 
The lack of consensus about how to label this kind of treatment suggests that some doctors 
distinguish what they call “medically futile” (or physiologically futile) from “futile” 
treatment, highlighting the inherent ambiguity in the term. 
Discussion 
Despite objections to this terminology,15,16 doctors readily engaged with the concepts of 
“futility” and “futile treatment” when discussing their practice. These were familiar concepts 
recognised as having a role in decision-making about treatment. In contrast to the literature, 
where defining futility has been the subject of ongoing contention,21,22 participants broadly 
agreed about how futility was defined, with a focus on treatment that had a very low or zero 
chance of patient benefit. This aligns with the approach taken in the recently revised 
Australian Medical Association Position Statement on End of Life Care and Advance Care 
Planning (AMA Statement): “In end of life care, medically futile treatment can be considered 
to be treatment that gives no, or an extremely small, chance of meaningful prolongation of 
survival and, at best, can only briefly delay the inevitable death of the patient.”23, p5 Consistent 
with our findings, the AMA Statement also defines futile treatment as that which “no longer 
provides a benefit to a patient or treatment where the burdens of treatment outweigh the 
benefits.”23, p3 
Our findings differ, however, from the very limited body of earlier empirical work on how 
futility is defined. Solomon24 (in 1993) found that doctors preferred talking about futility in 
terms of “medical futility” or physiological futility, rather than value judgements about 
quality of life. Sibbald et al8 reported that ICU staff used a definition of futility that integrated 
resource use considerations. Our research included 12 doctors from ICU, but only three of 
these discussed resource use in their definition. Our different results, particularly compared 
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with the older Solomon study, may be the result of shifts to make medicine more patient-
oriented. Technological advances also mean prolonging life is increasingly possible and give 
quality of life issues, as opposed to just survival, greater prominence. 
Doctors did acknowledge variation in how the concept is clinically applied. This is inevitable 
when criteria are broad and qualitative, as participants noted. There was agreement that 
“patient benefit” is the test, but whether a particular treatment provides benefit can depend on 
from whose perspective this is assessed. Likewise, assessment of “chance of success” was 
described as subjective. This subjectivity underpins the long-standing debate about how 
useful futility is in guiding clinical decision-making. This study does not solve this problem, 
but demonstrates empirically that variability exists and highlights the need to be aware of 
differences in approach between clinicians, and between clinicians and patients and family. 
The decision-making process must be transparent to ensure that different perspectives are 
considered.  
Decisions about patient benefit must meaningfully involve patients and families. There is 
evidence indicating this may not always occur,25,26 although some participants specifically 
pointed to the importance of these discussions in their practice. Doctors may reach a view that 
treatment is futile, informed by their definition of futility and clinical indicators such as 
functional status, disease severity, and age. This should become a trigger for (perhaps 
repeated) discussions about treatment with the patient or family to understand their 
assessment of patient benefit, rather than a basis for unilateral decision-making.  
This approach appears to be reflected in the concept of “justifiable futile treatment”, at least 
where it is justifiable due to wider patient benefit. Doctors, based on clinical assessment, may 
provisionally decide that treatment is futile, but in discussions with patients and families 
wider notions of patient benefit may emerge which justify further treatment for a limited 
period and specific purpose. This terminology of “justifiable futile treatment”, containing as it 
does an internal contradiction, might be better rendered as “appropriate treatment, all things 
considered”.  
Different issues arise for the other type of justifiable futile treatment doctors spoke of, namely 
treatment provided for family needs. The AMA Statement23 specifically addresses “medically 
futile” treatment that nevertheless benefits patients in non-clinical ways, but does not make 
the same case for treatment that benefits family. Truog27 has argued that it may sometimes be 
ethically appropriate to provide such care, but there are questions about how far treatment, 
particularly where it is burdensome, should be continued to benefit others than the patient.28 
However, we note that patient needs and family needs may overlap,29 and ensuring that the 
family are in broad agreement with treatment decisions is often considered good clinical 
practice. For example, further treatment that allows preparation for death, including time for 
relatives to gather, may well be acceptable and appreciated by the patient.  
A limitation of this study is that the doctors interviewed volunteered to participate and so may 
have been interested in and had concerns about futile treatment. Further, these results may not 
be generalisable to treatment settings beyond public sector hospitals. Finally, this is a study of 
perceptions, and may not perfectly reflect actual behaviour. 
This research found that futility is a familiar term, readily engaged with by doctors, who said 
it was used and useful in the clinical setting. Doctors shared a conceptual understanding of 
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futility, from which a clear definition focused on patient benefit emerged. There was, 
however, a high degree of variability in how this definition was applied in the clinical setting, 
reflecting the qualitative nature of patient benefit. These findings suggest that clinicians using 
the concept of futility should be aware of this variability and the potential for subjectivity in 
their decision-making. Because doctors place patient benefit at the heart of futility, engaging 
with patients and families about their values and goals is a critical part of decisions to limit or 
stop treatment. 
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Element of futility Number of doctors 
(Proportion)  
Nature of patient benefit 96 (100%) 
Level of benefit 89 (93%) 
Burdens outweigh benefits 75 (78%) 
No benefit (will not work) 59 (61%) 
Insignificant benefit (not sustained, not meaningful) 42 (44%) 
Type of benefit 84 (88%) 
Inadequate quality of life (independent of quantity of life) 76 (79%) 
Does not provide quantity or quality of life 40 (42%) 
No gain in physical functioning or symptom control 20 (21%) 
Does not lengthen life (independent of quality of life) 14 (15%) 
Overall outcome 81 (84%) 
Death is imminent 66 (69%) 
Would not address underlying terminal condition or change 
ultimate outcome 
60 (63%) 
Not reversible 28 (29%) 
Investigation would not change management 5 (5%) 
Does not achieve a goal of treatment (patient, family, doctor) 45 (47%) 
Benefit generally (not further defined) 27 (28%) 
  
Chance of patient benefit 70 (73%) 
Insignificant or low chance of benefit 59 (61%) 
No chance of benefit 31 (32%) 
Below numeric threshold of success for specific cases (answers 
ranged from <0.1% to 10%) 
18 (19%) 
Below numeric threshold of success applicable to all cases (answers 
ranged from <0.1% to 10%) 
4 (4%) 
  
Not worth the resources 17 (18%) 
  
TOTAL 96 (100%) 
Table 1.  Elements in doctors’ definitions of futility 
  
 
Clinical factor Number of doctors* 
(Proportion)  
Severity of disease 67 (74%) 
Functional status 64 (71%) 
Age 53 (59%) 
Multiple comorbidities 51 (57%) 
Diminished or no capacity 49 (54%) 
Patient trajectory (e.g. deteriorating condition, sentinel event, acute 
decline) 
36 (40%) 
Table 2. Clinical factors potentially relevant to futility determination 
*Discussed by 90 doctors 
  
Appendix 1: Quotes from participants on key issues 
Futility is about patient benefit 
Quote A: “Treatment that's not going to improve a patient's longevity or quality of life 
essentially.  …  If you can't provide either of those, and/or is going to prolong some potential 
suffering, and there is a very low likelihood of being able to reverse that problem … then as I 
said, I don't think you should provide it just for the sake of providing it… you've got to 
provide treatment that's actually going to have some benefit, and if you can't achieve that, 
then what are you doing it for?” (Cardiology consultant, male) 
Quote B: “Treatment that's unlikely to benefit the patient, basically. … Either in length of life, 
quality of life or any of the things that would be important to the patient.” (Oncology 
consultant, male) 
Quote C: “… there is no measurable or meaningful benefit to that patient to have received or 
receive that treatment. … In improved quality of life, function, physical functioning and 
improved health in the broad sense.” (Palliative Medicine consultant, female) 
Quote D: “Treatment that's not going to improve quality of life, improve symptoms or 
increase life expectancy.” (Respiratory Medicine consultant, female) 
Quote E: “To me the quality of life is also a big factor.  So if it's going to be three miserable 
months then I probably wouldn't do it, but if it's going to be three really good months and they 
were young and keen and wanted something done, I think they're all factors basically.” 
(Oncology consultant, female) 
Quote F: “Or another way I might say sometimes is the burdens of this treatment far outweigh 
any benefits and it is not in your loved one's best interest from a medical point of view to do 
it.  So usually it'll be about portraying, usually it's – so what I see is futile is where the 
burdens of the treatment outweigh, quite severely or significantly, any potential benefit.” 
(Pallative Medicine consultant, male)  
Role of resources in futility 
Quote G: “It's a quality of life [assessment] but I guess what I'm really referring to is, to be 
honest, is the extent of the resources you're actually going to use to get a certain outcome.” 
(Emergency Medicine consultant, female) 
Quote H: “Then I guess as a distant third [factor,] there is the community, the hospital, the - 
that bigger picture thing. Is this a waste of money, a waste of resources? If we do this are we 
not going to be able to do something else; those sort of things do factor in a little bit.” (Renal 
Medicine consultant, female) 
Quote I: “… it's often treatment with a high resource cost but also high impact to the patient. 
So for lower resource impacts and lower impact to the patient, it matters much less. To 
operate, to not operate is important. To put up some IV fluids versus not is a much lower level 
decision to make, in other words, because the impact is not as great.” (Emergency Medicine 
consultant, male) 
Assessing likelihood of patient benefit  
  
Quote J: “Nothing in medicine is all or nothing. We're used to this idea of uncertainty all the 
time… There's only such a small number of things that would fit into 100 per cent beneficial 
or 100 per cent futile.” (Renal Medicine consultant, female) 
Quote K: “But mostly you have to in medicine go with the odds. If the odds are very much 
swayed in the fact that this isn't going to help the person, this person is going to die almost no 
matter what I do, then you've got to expect that that's what is going to happen. It's wrong to 
try and build false hope in people when really there is very little false hope there.” (Geriatric 
Medicine consultant, male) 
Quote L: “… no chance or virtually no chance of a positive outcome or an improvement in 
the patient's condition with the proposed treatment. … You'd have to be pretty confident to 
use that word futile.  I've rarely written that on the chart.  I actually don't write that word.” 
(Respiratory Medicine consultant, male) 
Quote M: “… no chance of survival as being futile or no chance of a meaningful recovery.” 
(Neurosurgery consultant, female) 
Quote N: “… no chance of an outcome, that the patient would think was reasonable.” 
(Neurosurgery consultant, female) 
Difficulties in defining futility 
Quote O: “It's very hard to define futility, as I said, in a way that gives you an all 
encompassing definition that can be just easily applied to all of the situations. It is just trying 
to weigh up the pros and the cons and when the cons far outweigh the pros then it's futile. But 
what the people involved consider are the pros and the cons and the strength of each - what 
weight is put on the different pros and cons is different. That's where the one definition fits all 
doesn't fit very well.” (Renal Medicine consultant, female) 
Quote P: “That's really tough.  Futile treatment is providing ongoing treatment or life 
sustaining measures in a situation where the prospect of survival for any reasonable period of 
time, or survival with an appropriate, or with a reasonable quality of life, yes, where the 
prospect of that is remote.  The trouble is, it's very hard, what's remote?  What's a reasonable 
quality of life?  What's a reasonable prospect of survival?  Those things, and it's those grey 
zones that make it really difficult… What I would view as futile would be different to other 
doctors, would be different to patients.” (Renal Medicine consultant, male) 
More objectivity is possible in futility 
Quote Q: “... a lot of people think futility decisions are subjective.  That's ignorance.  It's not.  
There is - although it's not fool proof, one hundred per cent objective, there is some 
objectivity coming into the discussion from all the literature that comes around from the 
world.  You need … to try and keep yourself abreast of what's happening in the literature.  
Understand different patient groups, who are likely to do well, who are not likely to do well, 
so understanding of current literature and what's happening and what others have done, learn 
from others' mistakes.” (ICU consultant, male) 
Justifiable futile treatment 
  
Quote R: “Sometimes just giving them a few days, so it can actually sink in. While treating 
them isn't going to get them out of hospital or isn't even going to keep them alive, they're 
going to die anyway. Having a little bit of time to (1) for them to accept it, (2) for family to 
accept it and to come to terms with that, is often useful. That's probably to be honest more 
often where I think more futile treatment - what could be classed as futile treatment, happens. 
I wouldn't [call that futile], but some people would. You can argue it is because someone still 
dies, but I think there are things that you gain from it.” (Respiratory Medicine consultant, 
male) 
Quote S: “It's difficult, isn't it?  I suppose, futile treatment - what may be medically futile, in 
terms of the medical outcome, may still be beneficial from the point of view of giving the 
family and/or the patient time to adjust to the fact that their illness is terminal.  So, that's not 
really futile from that point of view.  From a practical point of view, I guess, that time frame 
usually tends to be fairly limited, anyway.  It's usually of the order of weeks to months before 
something serious happens.  It would be very unusual for someone like that to go on having 
years of treatment.  So… …it's a short term issue, usually.” (Renal Medicine consultant, 
male) 
  
Appendix 2: Interview Guide 
Note: these questions are to be used as a flexible guide. The interviewer will begin with a 
general question like those described, and use the other questions as prompts depending on 
what the participant says. The interview will be conversational, and participants will answer 
questions in their own words and address issues in the order they wish. 
General questions 
Initial question: Can you please describe a situation from your experience (one you were 
responsible for or one from a colleague) when a person got treatment at the end of life you 
didn’t think they should have had? 
 Why was this treatment provided? 
 How did you feel about this experience? 
 What do you think could have been done differently (if anything)? 
 
What about a situation where a patient didn’t get treatment that you thought they should have 
had? 
Can you describe a situation where treatment at the end of life was appropriately withdrawn? 
Describe a situation where a decision was made to withhold or withdraw treatment that 
resulted in a poor outcome? 
Have you ever given treatment you knew was futile (ie likely to be ineffective)?  Why? 
 What factors led to the decision? 
 Why was treatment withheld/withdrawn? 
 Why did you think that others/self thought treatment was futile/inappropriate? 
 Why do you think that others/self thought treatment was appropriate? 
 How did you feel? 
 What was your colleague’s reaction? 
 What do you think could have been done differently (if anything?) 
 
  
Prompts  
 Family 
a. What role, if any, do you think family members play in the provision of futile 
treatment? 
b. What role, if any, do you think patients play in the provision of futile 
treatment? 
c. How often is futile treatment given just because family requests it? 
 
 Interpersonal dynamics/communication 
a. Some believe that communication plays a role in futile treatment.  What do 
you think about this? (i.e. communication with other staff, family, patient) 
b. Some believe that expectations play a role in futile treatment.  What do you 
think about this?  (i.e. expectations of other staff, family, patient, self) 
 
 Institutional culture 
a. Why do doctors make varying decisions about when to withhold or withdraw 
treatment at the end of life? 
b. Is your practice similar to others in your specialty?  Why or why not?  
c. Interaction/opinions of nurses, registrars, other staff   
d. Some say that this treatment is provided because doctors don’t have enough 
time to have adequate conversations because of workload.  What do you 
think about this? 
 
 Training 
a. What training (if any) did you receive in relation to how to deal with end of 
life care?  Deciding when to cease active treatment?  
b. Nature, duration, place of training 
c. What, if anything, should be done to change this training? 
 
 Resources (look for cues from participant) 
a. Some say resources are a factor in assessing whether or not to offer treatment 
that may be futile.  What do you think about this? 
b. Some say that by providing treatment that is futile (even when there is some 
justification) others miss out on beneficial treatment.  What do you think 
about this? 
 
 Law  
a. Some believe that if they do not provide treatment when a patient/substitute 
decision maker requests it, there may be legal consequences.  What do you 
think about this? 
b. What does the law say on this?  
c. What do you think of the law?  Is treatment provided because of it? 
d. Have you ever had a situation escalate to a legal proceeding? 
e. Thoughts on the legal proceeding? 
  
 
f. Does the law support your decisions in this area? 
g. Would an increased understanding of the law assist? 
 
 Policy 
a. Are there any policies/practices in your department/hospital/QHealth that 
deal with futile treatment at the end of life?   
b. What do they say? 
c. What do you think of these? 
d. Do you use them in practice? 
e. What about professional/ethics guidelines?  Do they address this? What do 
you think of them? 
 
 Nature of futile treatment 
a. Think of instances in other specialties when this occurs? Which ones? 
b. What is the nature of futile treatment provided? 
(Resuscitation/medication/procedures, etc)? 
c. What about your own specialty (discipline, department) – any examples? 
d. How frequently do you perceive futile treatment occurs in your department? 
e. Main reason that futile treatment is provided? 
 
 Definition 
a. What do you mean by futile treatment? 
b. Can you define futile treatment? 
 
 Improvement 
a. Is it a problem?  What troubles you the most about it? (harm to patient, 
resource use, doctor’s autonomy, etc) 
b. What do you think needs to happen (if anything) to address the issue of futile 
treatment? 
 
 
Case example 
 John is an 84 year old male with advanced dementia and end stage bowel cancer 
which has metastasised 
 He is admitted from the high care unit of an residential aged care facility to hospital 
with abdominal pain 
 It is possible to undertake surgery, but this is expected to have limited, if any, benefit 
 John’s daughter demands the operation despite the poor prognosis 
 
  
 
What to do (listen for cues from participant): 
1. Administer treatment?  When?  Why this point? 
2. What information would you want? 
3. How would you make this decision?  Who would you speak to? 
4. Any laws/policies/processes affecting your decision? 
5. Cost considerations? 
6. What if John did not have dementia and himself was requesting futile treatment? 
 
Categorise 
 Continue even if know is futile? 
 Or stop because know is futile? 
 
